FDA Approves LEUPROLIDE ACETATE — NorthStar RxLLC

# FDA Approves NorthStar RxLLC's Generic Leuprolide Acetate Injection NorthStar RxLLC received FDA approval for its generic leuprolide acetate subcutaneous injection, expanding the competitive landscape for this widely-used hormone therapy used in prostate cancer, endometriosis, and uterine fibroids. The approval is expected to increase price competition and improve patient access to this established therapeutic, potentially eroding market share for branded versions.